Genedx Holdings Corp Stock Net Income
| WGS Stock | 71.94 0.92 1.26% |
GeneDx Holdings Corp fundamentals help investors to digest information that contributes to GeneDx Holdings' financial success or failures. It also enables traders to predict the movement of GeneDx Stock. The fundamental analysis module provides a way to measure GeneDx Holdings' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to GeneDx Holdings stock.
| Last Reported | Projected for Next Year | ||
| Net Loss | -175.8 M | -184.6 M | |
| Net Loss | -494.1 M | -469.4 M | |
| Net Loss | -175.8 M | -184.6 M | |
| Net Loss | (7.23) | (7.59) | |
| Net Income Per E B T | 0.99 | 1.09 |
GeneDx | Net Income |
GeneDx Holdings Corp Company Net Income Analysis
GeneDx Holdings' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current GeneDx Holdings Net Income | (175.77 M) |
Most of GeneDx Holdings' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GeneDx Holdings Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
GeneDx Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for GeneDx Holdings is extremely important. It helps to project a fair market value of GeneDx Stock properly, considering its historical fundamentals such as Net Income. Since GeneDx Holdings' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of GeneDx Holdings' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of GeneDx Holdings' interrelated accounts and indicators.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, GeneDx Holdings Corp reported net income of (175.77 Million). This is 151.5% lower than that of the Health Care Equipment & Supplies sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 130.78% higher than that of the company.
GeneDx Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GeneDx Holdings' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of GeneDx Holdings could also be used in its relative valuation, which is a method of valuing GeneDx Holdings by comparing valuation metrics of similar companies.GeneDx Holdings is currently under evaluation in net income category among its peers.
GeneDx Holdings ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, GeneDx Holdings' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to GeneDx Holdings' managers, analysts, and investors.Environmental | Governance | Social |
GeneDx Fundamentals
| Return On Equity | -0.36 | ||||
| Return On Asset | -0.0827 | ||||
| Profit Margin | (0.31) % | ||||
| Operating Margin | (0.10) % | ||||
| Current Valuation | 2.12 B | ||||
| Shares Outstanding | 27.47 M | ||||
| Shares Owned By Insiders | 18.13 % | ||||
| Shares Owned By Institutions | 70.36 % | ||||
| Number Of Shares Shorted | 2.34 M | ||||
| Price To Book | 10.37 X | ||||
| Price To Sales | 7.49 X | ||||
| Revenue | 202.57 M | ||||
| Gross Profit | (26.75 M) | ||||
| EBITDA | (136.46 M) | ||||
| Net Income | (175.77 M) | ||||
| Total Debt | 119.77 M | ||||
| Book Value Per Share | 7.45 X | ||||
| Cash Flow From Operations | (180.15 M) | ||||
| Short Ratio | 3.20 X | ||||
| Earnings Per Share | (3.09) X | ||||
| Target Price | 80.83 | ||||
| Number Of Employees | 1 K | ||||
| Beta | 2.18 | ||||
| Market Capitalization | 2 B | ||||
| Total Asset | 473.67 M | ||||
| Retained Earnings | (1.3 B) | ||||
| Working Capital | 123.52 M | ||||
| Net Asset | 473.67 M |
About GeneDx Holdings Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze GeneDx Holdings Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GeneDx Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GeneDx Holdings Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for GeneDx Stock Analysis
When running GeneDx Holdings' price analysis, check to measure GeneDx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneDx Holdings is operating at the current time. Most of GeneDx Holdings' value examination focuses on studying past and present price action to predict the probability of GeneDx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneDx Holdings' price. Additionally, you may evaluate how the addition of GeneDx Holdings to your portfolios can decrease your overall portfolio volatility.